The Effect of the Patient Activation Measure on Chronic Care
Using the Patient Activation Measure (PAM) to Improve Patient Self-Management of Hypertension
1 other identifier
interventional
283
1 country
1
Brief Summary
We will test - in a chronically ill managed long term care population - the effectiveness of an intervention that provides nurse Care Managers with an inventory of evidence-based practices tailored to patients with different levels of knowledge, skills and confidence to engage in self-care management. Specifically, we will develop a "change package" of evidence-based hypertension (HTN) management strategies geared to patients scoring at the four different stages of activation on the Patient Activation Measure (PAM). We will randomly assign a group of interdisciplinary teams in the managed long-term care plan to intervention or control status and will train the Care Managers on the Intervention teams to use the change package in conjunction with a patient's PAM score to design - with the involvement of the patient - an individualized HTN management plan. We then will assess the impact of the intervention on patient activation and outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 hypertension
Started Apr 2006
Typical duration for phase_1 hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2006
CompletedFirst Posted
Study publicly available on registry
March 6, 2006
CompletedStudy Start
First participant enrolled
April 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedMarch 17, 2008
May 1, 2006
11 months
March 2, 2006
March 12, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
changes in patients' PAM scores
six months
differences in patients' HTN knowledge
six months
adherence to HTN medication and diet recommendations
six months
average changes in patients' systolic and diastolic BP
six months
percent of patients who maintain BP control, among those with controlled baseline BP
six months
Interventions
Eligibility Criteria
You may qualify if:
- active VNS CHOICE patient on one of the 22 Intervention or Control teams at the start of the intervention period,
- in care for less than or equal to 730 days,
- a formal diagnosis of HTN (using appropriate ICD codes recorded in the patient record), and
- English speaking.
You may not qualify if:
- moderate or severe cognitive impairment as measured by a six-item short portable mental status assessment
- organic brain disease dx in as one of the top 5 dx as measured by information in OASIS, the uniform home care assessment instrument mandated by the Centers for Medicare and Medicaid Services
- End Stage Renal disease dx as one of the top 5 dx as measured by information in OASIS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Visiting Nurse Service of New York Center for Home Care Policy & Research
New York, New York, 10001, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda M Gerber, Ph.D.
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 2, 2006
First Posted
March 6, 2006
Study Start
April 1, 2006
Primary Completion
March 1, 2007
Study Completion
March 1, 2007
Last Updated
March 17, 2008
Record last verified: 2006-05